Dlouhy I, Maia T, Viegas D, Abreu N, Cabeçadas J, da Silva MG. Notable clinical activity of immune checkpoint inhibitors with or without brentuximab vedotin in relapsed or refractory gray zone lymphoma. haematol [Internet]. 2020Sep.10 [cited 2026Jul.26];. Available from: https://haematologica.org/article/view/14291